Understanding how your body reacts to medications is crucial, and semaglutide is no exception
Injection site reactions (15-25%), occasional nausea (5-10%), and rare dizziness (3-7%) are the most commonly reported issues, and these typically resolve within hours to days without treatment
Early data suggest that petrelintide might offer improved tolerability and effective weight loss compared to existing treatments
Researchers examined data from 227,866 people between 2006 and 2023 and found that those taking semaglutide experienced 36 percent fewer alcohol-related hospital visits compared to those not taking the medication
People with obesity often perceive tastes less intensely, and they have an inherently elevated desire for sweet and energy-dense food, study lead Mojca Jensterle Sever , PhD, of the University Medical Centre in Ljubljana, Slovenia, said in a statement